AKLIEF 50 MCG — DIN 02494175
TRIFAROTENE : 50 MCG · GALDERMA CANADA INC · CREAM · wholesale supply in Canada
Health Canada status: MARKETED
What is AKLIEF?
AKLIEF 50 MCG contains TRIFAROTENE : 50 MCG. It is listed in the Health Canada Drug Product Database under DIN 02494175, held by GALDERMA CANADA INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 28-Nov-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is AKLIEF used for?
Topical treatment of acne vulgaris of the face and/or trunk in patients 12 years of age and older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Trifarotene cost around the world?
Trifarotene is listed on 7 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Czechia publishes a max producer price (ex-factory); Greece publishes a producer price (ex-factory); Iceland publishes a max wholesale. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United Arab Emirates | public | 1 | 2 | AED███.██ |
| Czechia | max producer price (ex-factory) | 1 | 1 | CZK███.██ |
| Greece | producer price (ex-factory) | 1 | 1 | EUR███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
| Luxembourg | reimbursement | 1 | 1 | EUR███.██ |
| Saudi Arabia | public | 1 | 1 | SAR███.██ |
| South Africa | single exit price | 1 | 1 | ZAR███.██ |
8 pack listings across 7 brand entries and 6 price bases, refreshed 05 Sep 2026. Ranges span every Trifarotene pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MCG |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
| Pack configuration (monograph) | 2 g tube (sample); 15 g, 30 g, 45 g, and 75 g airless pump bottles. |
| Storage | Not explicitly stated in the provided text (section header exists but content is missing), though typically 15-30°C for such products. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Trifarotene |
|---|---|
| ATC code | D10AD06 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02494175 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2494175 |
| Brand name | AKLIEF |
| Generic / active ingredient | TRIFAROTENE : 50 MCG |
| Market authorization holder | GALDERMA CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | D10AD06 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D10AD |
| Current status | MARKETED |
| Status date | 28-Nov-2019 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Apply a thin layer to affected areas of face and/or trunk once daily in the evening on clean, dry skin. Wash hands after application. Use of moisturizer is recommended.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to drug or ingredients; patients with eczema or seborrheic dermatitis; pregnancy; women planning a pregnancy.
Warnings and precautions
For external use only. Avoid contact with eyes/lips. Avoid excessive sunlight/UV exposure. May cause local cutaneous reactions (erythema, dryness). Avoid "waxing" on treated skin.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
2 · Same class — other molecules in ATC D10AD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Tretinoin | ALTRENO · REJUVA-A · RENOVA · RETIN-A · +16 more | 31 | 6 | Yes |
| Adapalene, Combinations | SANDOZ ADAPALENE / BENZOYL PEROXIDE · SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE · TACTUPUMP · TACTUPUMP FORTE · +2 more | 6 | 6 | Yes |
| Adapalene | DIFFERIN · DIFFERIN XP | 5 | 3 | Yes |
| Trifarotene | AKLIEF | 1 | 1 | Yes |
| Tretinoin, Combinations | RETISOL-A | 4 | 0 | Not in Canada |
| Isotretinoin | ISOTREX GEL 0.05% | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D10A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D10AE | Benzoyl Peroxide · Benzoyl Peroxide, Combinations | 214 | 35 |
| D10AF | Chloramphenicol, Combinations · Clindamycin · Clindamycin, Combinations · Erythromycin, Combinations | 23 | 8 |
| D10AX | Aluminium Oxide · Azelaic Acid · Clascoterone · Dapsone · Various Combinations | 6 | 3 |
| D10AA | Corticosteroids,Combinations For Treatment Of Acne · Methylprednisolone | 3 | 0 |
| D10AB | Sulphur · Sulphur, Combinations | 33 | 0 |
4 · Fixed-dose combinations with Canadian supply
| Product | Active ingredients | Holder | Status | DIN |
|---|---|---|---|---|
| CABTREO | CLINDAMYCIN PHOSPHATE 1.2 %; ADAPALENE 0.15 %; BENZOYL PEROXIDE 3.1 % | BAUSCH HEALTH, CANADA INC. | MARKETED | 02550423 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.